上下期目录列表 Journal Of Modern Oncology

[2499-2505] Regulation of Ndfip1 expression by miR-155-5p affects the malignant biological behavior of breast cancer cells and its related mechanisms

[XU Rui,QIAN Jun,ZHANG Mingliang,ZHANG Ligong,GUO Chenxu,YIN Faxiang,CHU Yunmian]

2024 14 [Abstract]()

[2506-2511] Dopamine-modified hydrogels loaded with cisplatin inhibit the proliferation of KRAS mutant lung cancer cells

[LIU Zhijin¹,ZHANG Jian¹,GAN Lin¹,LYU Xiaobin^1,2,ZHANG Weihua³,XU Jun¹]

2024 14 [Abstract]()

[2511-2517] miR-623 regulates esophageal squamous cell carcinoma cell proliferation,migration and invasion by targeting MMP1

[FEI Song,WU Weidong,LI Dan,FANG Mingxing,JIN Bo]

2024 14 [Abstract]()

[2518-2523] Recombinant Newcastle disease virus rL-RVG induces lung adenocarcinoma PC9 cell pyroptosis by modulating the NLRP3/Caspase1/GSDMD pathway

[LI Yang¹,HE Yingjue¹,GONG Kewen¹,TIAN Yidu¹,WANG Chen¹,YAN Yulan^1,2]

2024 14 [Abstract]()

[2523-2529] Preliminary study on the role of the lncRNA AL022344.4 in promoting invasion and migration of lung adenocarcinoma cells

[NI Linfeng¹,WANG Wei¹,PANG Min²,LIU Chaofeng²,WANG Hailong¹,SUN Yan³]

2024 14 [Abstract]()

[2530-2534] MTDH interference promotes drug sensitivity and cell apoptosis in glioma resistant to temozolomide

[MENG Liang¹,WANG Yuefei¹,TAO Liang¹,FAN Wen¹,TU Qin¹,ZHU Yuan¹,YU Xiaoxiang¹,DAI Xiaoqin²]

2024 14 [Abstract]()

[2535-2541] Targeted inhibition of GOT1-mediated iron death pathway reverses cisplatin resistance in esophageal squamous cell carcinoma cells

[ZHOU Shasha¹,GUO Zhiyuan¹,QI Weihua¹,YANG Chen¹,ZHANG Xin²]

2024 14 [Abstract]()

[2541-2545] Analysis of clinical characteristics of patients with oral malignant tumor（773 cases）

[ZHA Chengpeng,LI Lei,RAO Jinhui,ZHANG Wenda,LEI Qian,XIE Tao,ZHANG Minyue,SUN Chuanzheng]

2024 14 [Abstract]()

[2546-2554] The expression of CST4 and TGFB2 in esophageal cancer tissues and their clinical significance

[GUO Jiayi¹,HAN Yuanxing²,SONG Zhengyu¹,ZHANG Haiping¹,EDRISAWUT^1,3]

2024 14 [Abstract]()

[2554-2560] Construction of prediction model of non-small cell lung cancer patients based on serum tumor markers

[GUO Jiajia,GAO Yongyue,MAO Zhezhe]

2024 14 [Abstract]()

[2561-2565] The expression of UBE2S in esophageal squamous cell carcinoma and its clinical significance

[LI Wan,LI Mengyan,LIU Xianwen,LYU Yuanyuan,MA Yuqing]

2024 14 [Abstract]()

[2566-2569] The clinicopathological features of breast cancer patients with low HER-2 expression

[YU Maowu,ZHOU Sujuan,CHEN Yun]

2024 14 [Abstract]()

[2570-2573] Relationship between genetic polymorphism of X-ray repair cross-complementing group 1(XRCC1) and clinical outcomes of advanced gastric cancer receiving oxaliplatin plus capecitabine chemotherapy

[HAN Lei¹,DONG Ningning²]

2024 14 [Abstract]()

[2574-2578] The clinical value of preoperative peripheral blood platelet to lymphocyte ratio and fibrinogen in the prognosis of colon cancer patients undergoing radical surgery

[YE Yayun¹,MENG Xiangyu²,XU Jiaqing¹,WANG Junbin¹]

2024 14 [Abstract]()

[2579-2585] Analysis of related risk factors and establishment of prediction model for postoperative hypoalbuminemia in patients with gastrointestinal tumors

[LI Zhuang¹,WANG Shanshan²,DING Lirong¹,SU Zhen¹,LIU Hailin¹,TAO Guoquan¹,ZHANG Zhijie¹]

2024 14 [Abstract]()

[2585-2590] Impact of ASXL1 mutated sites and co-mutated genes on the prognosis of patients with myeloid neoplasms

[WEI Zixiu¹，CHENG Juan²]

2024 14 [Abstract]()

[2591-2595] Analysis of prognostic factors in children with non-Hodgkin' s lymphoma

[WANG Ye，ZHANG Linlin，CHI Zuofei，SUN Ruowen，JIANG Zehui，XU Gang]

2024 14 [Abstract]()

[2596-2600] Expression of p-ERK5 and WT-1 in high-grade serous ovarian cancer and their relationships with clinicopathological features

[WANG Yanmin^1，2,GUO Yanjuan¹,LIU Conghui¹,CHEN Yan¹]

2024 14 [Abstract]()

[2601-2606] Analysis of gene mutation and related clinical characteristics of cervical cancer based on next generation sequencing

[LI Bin^1，2,HE Dongling¹，JIANG Dewen^1，2，LYU Qing^1，2，ZHOU Xiao^1，2，LIU Yanjie^1，2]

2024 14 [Abstract]()

[2606-2614] Comparative analysis of DBT imaging and clinicopathological features of ultrasonically suspected ductal carcinoma in situ with micro-invasion and ductal carcinoma in situ

[LI Hongen，TANG Dawei，CHENG Jialing，LIN Xing，ZENG Yihui，WANG Xia]

2024 14 [Abstract]()

[2615-2619] Clinical characteristics and imaging manifestations of splenic sclerosing angiomatoid nodular transformation

[ZHANG Jiaqi^1，2,WANG Hui³,LI Haining¹,ZHANG Li²,ZHANG Ming¹]

2024 14 [Abstract]()

[2620-2624] The expression of PDCD4 and miR-107 in penile cancer tissue and their relationship with patient prognosis

[WANG Zhi^1，2,3,HE Changhai²，DONG Biao¹，QIU Xuede³，LI Baoan²，ZHAO Qi²，WANG Hong²，ZHU Haidong²，LIU Junfeng²，LIU Zhengdao²，LYU Mingzhu⁴，JI]

2024 14 [Abstract]()

[2625-2629] Expression of Mis18β in bladder cancer tissues and its clinical significance based on multiplex bioinformatics database

[CAO Wenjing^1，2，SONG Xuan²，ZHANG Zongliang³，YUAN Jiangshui²，SONG Weiqing^1,2]

2024 14 [Abstract]()

[2633-2637] The research progress of cell free RNA as a biomarker for colorectal cancer

[MA Jing¹,FENG Zehui²,DANG Miao²,XING Jinliang²,FANG Fang¹,LIU Yang³]

2024 14 [Abstract]()

[2637-2640] Progress of dermatopontin in tumor research

[FANG Yi¹，GUO Xueyao¹，SHAO Hongjing¹，ZHENG Xiaoyun¹，LIU Ye¹，LI Yang²]

2024 14 [Abstract]()

[2641-2646] Spindle and KT associated 2(SKA2):A universal tumour biomarker and a potential therapeutical target

[CEN Meizhi,GAO Lu,REN Mingqiang]

2024 14 [Abstract]()

[2647-2651] Exploring the biomolecular mechanism of reduced graphene oxide in the treatment of cancer

[WU Jianze^1，2,WANG Dequan^1，2,CHEN Huiguang^1，2,LI Jia^1，2,WU Qingming^1，3]

2024 14 [Abstract]()

[2652-2656] Pathogenesis and therapeutic progress of breast cancer with receptor from "positive to negative"

[HAN Ying¹,DI Lijun²]

2024 14 [Abstract]()

[2657-2661] Research progress on the role of exosomes in tumor radiotherapy

[HE Xiuling¹,WANG Quan²,DUAN Xuezhang²]

2024 14 [Abstract]()

[2661-2665] Research progress on the relationship between kinesin family member 2C and malignant tumors

[MENG Qi,ZHOU Yi]

2024 14 [Abstract]()

[2666-2669] Research progress of long non-coding RNA-MALAT1 in gliomas

[XU Libo^1,2，YUAN Kaikun^1,2，LI Qingsong^1,2]

2024 14 [Abstract]()

[2669-2674] Research progress of PD-1/PD-L1 inhibitors plus lenvatinib in recurrent or metastatic gynecologic tumors

[YANG Rui,MIN Jie,LI Junqiang,SU Haichuan]

2024 14 [Abstract]()

[2674-2680] Research progress of CAV1 in tumor chemosensitivity and chemoresistance

[ZHANG Weilin¹，WU Yadong²]

2024 14 [Abstract]()

SITEMAP